USPTO serial 79296059
IMPLAVAX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 24, 2021
- Examiner
- PARK, JENNY K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with IMPLAVAX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Medical and veterinary research and development services; medical and veterinary device development services; pharmaceutical drug and vaccine development services; pharmaceutical drug and vaccine delivery system development services; preparation and/or formulation of pharmaceuticals, namely, pharmaceutical drug and vaccine development services; scientific research into vaccines; medical and veterinary device and product testing services; provision of information relating to the aforesaid services, namely, medical and veterinary research and development services, medical and veterinary device development services, pharmaceutical drug and vaccine development services, pharmaceutical drug and vaccine delivery system development services, pharmaceutical drug and vaccine development services, scientific research into vaccines and medical and veterinary device and product testing services; consultancy in relation to the aforesaid services, namely, medical and veterinary research and development services, medical and veterinary device development services, pharmaceutical drug and vaccine development services, pharmaceutical drug and vaccine delivery system development services, pharmaceutical drug and vaccine development services, scientific research into vaccines and medical and veterinary device and product testing services; none of the aforesaid services relating to the treatment of cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 24, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 28, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 4, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 3, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 24, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 24, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 8, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 8, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 19, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 27, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 26, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2021 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Mar 22, 2021 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jan 8, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 20, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 11, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 1, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 1, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 10, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 2, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 23, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 19, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 15, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |